These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society. Vinod K, Gedde SJ, Feuer WJ, Panarelli JF, Chang TC, Chen PP, Parrish RK. J Glaucoma; 2017 Aug; 26(8):687-693. PubMed ID: 28692597 [Abstract] [Full Text] [Related]
3. Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy. Sen M, Midha N, Sidhu T, Angmo D, Sihota R, Dada T. Ophthalmol Glaucoma; 2018 Aug; 1(2):88-98. PubMed ID: 32677614 [Abstract] [Full Text] [Related]
4. Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study). Mostafaei A, Taheri N, Ghojazadeh M, Latifi A, Moghaddam N. Int Ophthalmol; 2019 Oct; 39(10):2341-2351. PubMed ID: 30656509 [Abstract] [Full Text] [Related]
5. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up. Castejón MA, Teus MA, Bolivar G, Paz-Moreno-Arrones J, Castaño B. J Glaucoma; 2018 Jan; 27(1):50-54. PubMed ID: 29117004 [Abstract] [Full Text] [Related]
6. The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure. Shin DH, Kim YY, Sheth N, Ren J, Shah M, Kim C, Yang KJ. Ophthalmology; 1998 Apr; 105(4):740-5. PubMed ID: 9544650 [Abstract] [Full Text] [Related]
7. Learning from the past: Mitomycin C use in trabeculectomy and its application in bleb-forming minimally invasive glaucoma surgery. Bell K, de Padua Soares Bezerra B, Mofokeng M, Montesano G, Nongpiur ME, Marti MV, Lawlor M. Surv Ophthalmol; 2021 Apr; 66(1):109-123. PubMed ID: 32450159 [Abstract] [Full Text] [Related]
8. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. Johnson MS, Sarkisian SR. J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882 [Abstract] [Full Text] [Related]
9. Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial. Tanna AP, Rademaker AW, de Moraes CG, Godfrey DG, Sarkisian SR, Vold SD, Ritch R. BMC Ophthalmol; 2016 Dec 29; 16(1):217. PubMed ID: 28034308 [Abstract] [Full Text] [Related]
10. Surgical trends in glaucoma management: The current Indian scenario. Ichhpujani P, Singla E, Kalra G, Bhartiya S, Kumar S. Int Ophthalmol; 2022 Jun 29; 42(6):1661-1668. PubMed ID: 35098417 [Abstract] [Full Text] [Related]
11. Phacotrabeculectomy using collagen matrix implant (Ologen® ) versus mitomycin C: a prospective randomized controlled trial. Wlaź A, Wilkos-Kuc A, Rozegnał-Madej A, Żarnowski T. Acta Ophthalmol; 2019 Sep 29; 97(6):e817-e826. PubMed ID: 30924600 [Abstract] [Full Text] [Related]
12. Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study. Salimi A, Kovalyuk N, Harasymowycz PJ. J Glaucoma; 2019 Nov 29; 28(11):989-996. PubMed ID: 31567908 [Abstract] [Full Text] [Related]
13. Survey of glaucoma surgical preferences and post-operative care in the United Kingdom. Rodriguez-Una I, Azuara-Blanco A, King AJ. Clin Exp Ophthalmol; 2017 Apr 29; 45(3):232-240. PubMed ID: 27726283 [Abstract] [Full Text] [Related]
14. National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK. Khan SA, Whittaker K, Razzaq MA, Arain UR. Int Ophthalmol; 2021 Apr 29; 41(4):1309-1316. PubMed ID: 33409733 [Abstract] [Full Text] [Related]
15. The role of trabeculectomy in the era of minimally invasive glaucoma surgery. Kalarn S, Le T, Rhee DJ. Curr Opin Ophthalmol; 2022 Mar 01; 33(2):112-118. PubMed ID: 35137708 [Abstract] [Full Text] [Related]
16. Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population. Koh V, Chen D, Aquino CM, Aduan J, Sng C, Chee LS, Chew P. Jpn J Ophthalmol; 2017 May 01; 61(3):245-252. PubMed ID: 28188405 [Abstract] [Full Text] [Related]
17. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. Iwao K, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S, Tanihara H. J Glaucoma; 2014 Feb 01; 23(2):88-94. PubMed ID: 22895522 [Abstract] [Full Text] [Related]
18. Outcomes of Glaucoma Drainage Device Implantation and Trabeculectomy With Mitomycin C in Glaucoma Secondary to Aniridia. Durai I, Pallamparthy S, Puthuran GV, Wijesinghe HK, Uduman MS, Krishnadas SR, Robin AL, Palmberg P, Gedde SJ. Am J Ophthalmol; 2021 Jul 01; 227():173-181. PubMed ID: 33737035 [Abstract] [Full Text] [Related]
19. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma. Senthil S, Rao HL, Babu JG, Mandal AK, Garudadri CS. Indian J Ophthalmol; 2013 Jul 01; 61(7):338-42. PubMed ID: 23571259 [Abstract] [Full Text] [Related]
20. Evaluating CO2 laser-assisted sclerectomy surgery with mitomycin C combined with or without phacoemulsification in adult Asian glaucoma subjects. Ho DCW, Perera SA, Hla MH, Ho CL. Int Ophthalmol; 2021 Apr 01; 41(4):1445-1454. PubMed ID: 33483900 [Abstract] [Full Text] [Related] Page: [Next] [New Search]